Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Organigram Global Inc.NASDAQ: OGI

Revenue · Q2 FY2026 · quarter ended Mar 2026

Revenue dips below year-ago levels

Q2 FY2026 revenue of CA$59.79M fell 8.9% year over year, behind the +41.2% change in trailing-twelve-month revenue. Sequentially, it fell 5.8% from the prior quarter.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 3 analysts of CA$350.92M (+88.6%) for the fiscal year ending Sep 2026, a step up from the +16.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$59.79M-5.8% QoQ
Last fiscal yearSep 2025
CA$186.09M+16.4% YoY
LTMMar 2026
CA$274.13M+41.2% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.9%+36.9%+45.7 pp
1 year+16.4%+88.6%+72.1 pp
3-year CAGR—+37.7%—
5-year CAGR+24.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2025
186.09M CAD
Year-over-year change
+16.4%
4-year CAGR
+23.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +41.2% is the 3rd highest of 9, against a peer median of +9.3%.
OGI Competitors
Revenue for OGI and competitors
Company Period LTM YoY 3-year CAGR
ACBAurora Cannabis Inc.LTM Mar 2026CA$310.87M CAD-9.4%+12.8%
OGIOrganigram Global Inc.LTM Mar 2026CA$274.13M CAD+41.2%—
INFUInfuSystem Holdings, Inc.LTM Mar 2026$142.4M USD+3.5%+9.3%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$135.16M USD—+5.0%
ELMDElectromed, Inc.LTM Mar 2026$71.75M USD+16.8%+15.4%
DERMJourney Medical CorporationLTM Mar 2026$64.68M USD+15.0%-5.7%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$32.72M USD+1033.9%+111.6%
HSDTSolana CompanyLTM Mar 2026$9.59M USD+2109.4%+97.0%
IVAInventiva S.A.FY2025€4.48M EUR-51.3%-28.3%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$1.78M USD-94.8%-70.7%
Peer median (excluding OGI) —+9.3%+9.3%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.